← FDA DRUG APPROVALS

FDA ANDA · ANDA087871

HYDROXYZINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA087871
TYPE
ANDA
ORIGINAL APPROVAL
1982-12-20
LATEST ACTION
2016-11-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

HYDROXYZINE HYDROCHLORIDEPrescription
HYDROXYZINE HYDROCHLORIDE 10MG · TABLET · ORAL
HYDROXYZINE HYDROCHLORIDEPrescription
HYDROXYZINE HYDROCHLORIDE 25MG · TABLET · ORAL
HYDROXYZINE HYDROCHLORIDEPrescription
HYDROXYZINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2016-11-08Labeling · Supplement 28 · standardAP
2016-03-30Labeling · Supplement 27 · standardAP
2014-06-03Labeling · Supplement 26 · standardAP
2000-01-10Manufacturing (CMC) · Supplement 22AP
1995-02-21Manufacturing (CMC) · Supplement 21AP
1988-11-14Labeling · Supplement 20AP
1988-04-25Manufacturing (CMC) · Supplement 14AP
1988-04-25Manufacturing (CMC) · Supplement 15AP
1985-07-08Manufacturing (CMC) · Supplement 8AP
1985-07-08Manufacturing (CMC) · Supplement 5AP
1984-08-21Manufacturing (CMC) · Supplement 4AP
1984-08-21Manufacturing (CMC) · Supplement 2AP
1984-08-21Manufacturing (CMC) · Supplement 1AP
1982-12-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →